Tiankang Biological (002100.SZ) released its financial results for the first half of the year, with a net profit attributable to the parent company of 3.38 billion yuan, an increase of 22.27%.

Zhijing Financial APP News, Tiankang Biology (002100.SZ) released its 2025 interim report, with the company's operating income reaching 8.847 billion yuan, a year-on-year increase of 10.68%. The net profit attributable to the shareholders of the listed company was 338 million yuan, a year-on-year increase of 22.27%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 314 million yuan, a year-on-year increase of 16.17%. The basic earnings per share were 0.25 yuan.